Clinical & Experimental Immunology · 2005 · 27 citations · 59 references
Life SciencesImmunologyPathologyClinical ImmunologyInflammationMucosal ImmunologyChronic InflammationGastrointestinal InflammationInflammatory Bowel DiseaseInflammatory Cell ResponsesInflammatory SignalingMucosal InflammationColonic InflammationInflammatory ActivationInflammatory Bowel Disease TherapyInflammatory Cytokine ProductionNuclear Factor Kappa B ActivationNuclear Factor Kappa B ModulationProinflammatory MediatorsTissue Infiltration By Inflammatory Cells
Infiltration by circulating inflammatory cells is a prominent local inflammatory feature of ulcerative colitis (UC). Several trials have suggested that leukocytapheresis by filtration can benefit patients with active UC. We investigated how this therapy might modulate the inflammatory response. Patients with active UC who were beginning repeated filtration leukocytapheresis were studied. Mononuclear cell preparations were obtained from blood before and after the first treatment, and expression of cytokine signalling components and the cell-proliferative response were analysed in vitro. Leukocytapheresis reduced lipopolysaccharide-induced production of proinflammatory cytokines (interleukin-1, -6, -8 and tumour necrosis factor-alpha, P < 0.05 for all) and activation of intracellular signalling components (nuclear factor-kappaB, mitogen-activated protein kinases, and signal transducer and activator of transcription-3), as well as surface expression of toll-like receptor-4 (P < 0.05) in mononuclear cells. The therapy also reduced the cell-proliferative response by mononuclear cells stimulated with sonicated bacterial preparations from autologous intestine (P < 0.05). These results indicate that activated mononuclear cells in the peripheral blood of patients with active UC are removed by leukocytapheresis and replaced by cells with a lower activation status. This replacement may partly explain the therapeutic benefit.
59
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Jean‐Pierre Hugot, Mathias Chamaillard, Habib Zouali et al. · Nature · 2001 · 5.6K citations
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Yasunori Ogura, Denise K. Bonen, Naohiro Inohara et al. · Nature · 2001 · 5K citations · Full text
Cortisone in Ulcerative Colitis
S. C. Truelove, L. J. Witts · BMJ · 1955 · 2.8K citations · Full text
Medicine, Immunology, Pathobiology +12
Unresponsiveness of MyD88-Deficient Mice to Endotoxin
Taro Kawai, Osamu Adachi, Tomohiko Ogawa et al. · Immunity · 1999 · 2.1K citations · Full text
Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy
Simon Lichtiger, D. H. Present, Asher Kornbluth et al. · New England Journal of Medicine · 1994 · 1.7K citations